We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Encysive Plans Phase III Clinical Trial for PAH Drug
Encysive Plans Phase III Clinical Trial for PAH Drug
March 21, 2008
Despite receiving three approvable letters from the FDA, Encysive has decided to go forward with a Phase III clinical trial of its pulmonary arterial hypertension (PAH) drug Thelin.